Skip to content

Redistribution of pulmonary blood flow as a cause for the progression of pulmonary hypertensionin after chronic thrombo-emboli.

Redistribution of pulmonary blood flow as a cause for the progression of pulmonary hypertensionin after chronic thrombo-emboli. - Cause of progression in chronic thromboembolic pulmonary hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31465
Enrollment
30
Registered
2008-02-14
Start date
2008-02-18
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic thromboembolic pulmonary hypertension AND increased pressure in pulmonary vessels due to bloodclots

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Mean pulmonary artery pressure (mPAP) > 25 mmHg. - Specific features of chronic thromboembolism on pulmonary angiography as assessed by radiologist(s). - No previous treatment of oral anticoagulation

Exclusion criteria

Exclusion criteria: - Presence of systemic inflammation. - Patients with pulmonary hypertension associated with collagen vascular disease, congenital heart disease, pulmonary venous hypertension, left heart failure, hypoxemic lung disease (COPD) - bad kidney function (creatinin > 120)

Design outcomes

Primary

MeasureTime frame
Changes assessed by MRI between obstructed and non-obstructed regions of the lungs by means of: - Pulmonary blood volume - Pulmonary blood flow - Mean transit time - Pulmonary vascular resistance

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)